Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

The stock is down 10.5% as 2 p.m. ET on Friday, while the stock is still up 224% in the last year. Here's why Hims & Hers stock fell this week. Where to invest $1,000 right now? Our analyst team ...

Hims & Hers reported its Q4 earnings this week. The company is growing quickly but faces a potential legal threat to its weight loss drug program. It is guiding for margin expansion and fast ...

Share on Pinterest Hims and Roman are telemedicine brands that provide quick shipping and discreet delivery for treatments for erectile dysfunction (ED), premature ejaculation (PE), and other ...

Shares of Hims & Hers Health(NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The telehealth company that sells dermatology, sexual health, and weight loss ...

According to the website, the site has a 4.5-star rating for the effectiveness of the products, discreet delivery, and professional medical guidance. Hims products are designed to prevent ...

In particular, Hims’ line of hair loss and erectile dysfunction treatments, can be easily added to your cart for discreet home delivery. Sign up for a subscription so you never have to worry ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to ...

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...